美国根据《减少通货膨胀法》规定降低主要药物的2027年价格,以降低医疗保健费用。 U.S. sets lower 2027 prices for major drugs under Inflation Reduction Act to cut Medicare costs.

美国公布了2027年的谈判价格,根据《减少通货膨胀法》降低了几种销售量最高的药品的成本。 The U.S. has released negotiated prices for 2027, lowering costs for several top-selling drugs under the Inflation Reduction Act. 最终确定的比率适用于数百万人使用的药物,包括癌症、糖尿病和自发免疫疾病的治疗。 The finalized rates apply to medications used by millions, including treatments for cancer, diabetes, and autoimmune diseases. 这些削减旨在降低医疗保险受益人的处方药费用,并减少联邦开支。 The reductions aim to lower prescription drug expenses for Medicare beneficiaries and reduce federal spending. 这项公告标志着执行该法的药物定价规定的关键一步。 The announcement marks a key step in implementing the law’s drug pricing provisions.